- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04985019
A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment of Panic Disorder
July 26, 2021 updated by: Jooyoung Oh, Gangnam Severance Hospital
The purpose of this study is to determine whether mobile-based virtual reality exposure treatement can reduce the symptoms of panic disorder and the symptoms of depression and anxiety than the waitlist group
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Gangnam Severance Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Meet Diagnostic Statistical Manual criteria for panic disorder(with or without agoraphobia) .
No change in drug dosage during the study period
Exclusion Criteria:
- Patients with a history of major neurological or significant medical illness, or met the diagnostic criteria of current substance misuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: I (Prepectoral)
VR treatment group Participants received the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for panic disorder.
|
Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.
Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.
|
|
NO_INTERVENTION: II (Subpectoral)
Waiting list Participants in a waiting list.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Panic Disorder Severity Scale
Time Frame: 4 weeks
|
The Panic Disorder Severity Scale consists of 7 items, each rated on a 5-point scale that assesses panic frequency, distress during panic, panic-focused anticipatory anxiety, phobic avoidance of situations, phobic avoidance of physical sensations, impairment in work functioning, and impairment in social functioning
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The heart rate variability
Time Frame: 4 weeks
|
The heart rate variability is the physiological recordings of the variation in the time interval between consecutive heartbeats in milliseconds
|
4 weeks
|
|
The Hamilton Rating Scale for Depression
Time Frame: 4 weeks
|
The Hamilton Rating Scale for Depression is a depression assessment scale and contains 17 items pertaining to symptoms of depression experienced over the past week
|
4 weeks
|
|
The State and Trait Anxiety questionnaire
Time Frame: 4 weeks
|
The State and Trait Anxiety questionnaire is has 20 items for assessing trait anxiety and 20 for state anxiety
|
4 weeks
|
|
The Korean Inventory of Depressive Symptomatology
Time Frame: 4 weeks
|
The Korean Inventory of Depressive Symptomatology is a self-report questionnaire that comprises symptoms of depression including melancholic, atypical and anxious symptoms
|
4 weeks
|
|
The Perceived Stress Scale
Time Frame: 4 weeks
|
The Perceived Stress Scale is is a measure of the degree to which situations in one's life are appraised as stressful
|
4 weeks
|
|
The Albany Panic and Phobia Questionnaire
Time Frame: 4 weeks
|
The Albany Panic and Phobia Questionnaire is a 27-item 9-point Likert scale that was designed to measure the distinct dimension of fear in various situations, and has three subscales: social phobia, agoraphobia, and interoceptive fear
|
4 weeks
|
|
The Hospital Anxiety and Depression Scale
Time Frame: 4 weeks
|
The Hospital Anxiety and Depression Scale is a 14-item scale that has anxiety and depression subscales;
|
4 weeks
|
|
The Body Sensations Questionnaire
Time Frame: 4 weeks
|
The Body Sensations Questionnaire is a 17-item 5-point Likert scale that evaluates how afraid and anxious a patient is when he/she feels the physical sensation of each item in an unstable state
|
4 weeks
|
|
The Anxiety Sensitivity Index
Time Frame: 4 weeks
|
The Anxiety Sensitivity Index is a 16-item measure tapping the fear of anxiety sensations, which is known to be a risk factor for the development of panic.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 14, 2018
Primary Completion (ACTUAL)
January 4, 2021
Study Completion (ACTUAL)
January 4, 2021
Study Registration Dates
First Submitted
July 26, 2021
First Submitted That Met QC Criteria
July 26, 2021
First Posted (ACTUAL)
August 2, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 2, 2021
Last Update Submitted That Met QC Criteria
July 26, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3-2018-0292
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Panic Disorder
-
Ibn Haldun UniversityCompletedWell Being | Anxiety Disorder (Panic Disorder or GAD)Turkey (Türkiye)
-
Philipps University Marburg Medical CenterGerman Federal Ministry of Education and ResearchCompletedPanic Disorder With Agoraphobia | Panic Disorder Without AgoraphobiaGermany
-
Beth Israel Medical CenterTerminatedPanic Disorder | Major Depressive Disorder With Panic AttacksUnited States
-
Ulrike WillutzkiUnknownDepression | Panic Disorder | Agoraphobia | Panic Disorder With Agoraphobia | Agoraphobia With Panic AttacksGermany
-
Charite University, Berlin, GermanyRecruitingGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder With Agoraphobia | Panic Disorder Without AgoraphobiaGermany
-
University of Santiago de CompostelaNot yet recruitingAnxiety Symptoms | Anxiety Disorder (Panic Disorder or GAD)Spain
-
Beth Israel Medical CenterCompletedPanic Disorder | Major Depression With Panic AttacksUnited States
-
Cairo UniversityNot yet recruitingAnxiety | Anxiety Disorder (Panic Disorder or GAD)Egypt
-
Region SkaneCompletedPanic Disorder (With or Without Agoraphobia)Sweden
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterUnknown
Clinical Trials on Arm I (Prepectoral)
-
Gangnam Severance HospitalRecruitingEating Disorder in Adolescents and Young AdultsKorea, Republic of
-
Gangnam Severance HospitalNot yet recruiting
-
Genentech, Inc.RecruitingSolid TumorIsrael, Spain, United States, France, Singapore, Australia, Canada, United Kingdom, South Korea
-
University Hospital A CoruñaActive, not recruitingQuality of Life | Breast Cancer | Surgery--ComplicationsSpain
-
Gangnam Severance HospitalRecruitingKnee OsteoarthritisKorea, Republic of
-
Gangnam Severance HospitalNot yet recruiting
-
Gangnam Severance HospitalRecruitingGastric CancerKorea, Republic of
-
Gangnam Severance HospitalCompletedSomatic Symptom DisorderSouth Korea
-
European Institute of OncologyActive, not recruiting
-
Gangnam Severance HospitalNot yet recruiting